patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: NASDAQ
If PLRS doesn't have any news to announce, they won't last on the NASDAQ for long.  They've got to know this.
Share
New Message
Please login to post a reply